IVIG for immune thrombocytopenia
Intravenous immunoglobulin (IVIG) is an antibody-based therapy used as a first-line treatment for immune thrombocytopenia (ITP). It works by interfering with the immune system’s ability to destroy platelets, helping to quickly raise platelet levels and reduce the risk of bleeding.